Furthermore, functional studies in hepatocellular carcinoma reveal KAT2A’s involvement in suppressing tumor cell proliferation, inducing G1 phase cell cycle arrest, and promoting apoptotic pathways [16]. The gene discussed is KAT2A; the disease is hepatocellular carcinoma.